NCT00397657View on ClinicalTrials.gov

Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis

PHASE4TerminatedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
Atherosclerosis
Interventions
DRUG

extended release niacin

Extended release niacin will be started at 1000mg and titrated to 2000mg once a day

DRUG

ezetimibe

Ezetimibe 10mg once daily

Trial Locations (2)

20307

Walter Reed Army Medical Center, Washington D.C.

20912

Washington Adventist Hospital, Takoma Park

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Walter Reed Army Medical Center

FED